IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RHO Capital Partners Inc

Q4 2020 Holdings

Filed 2021-02-10 | 5 holdings | $190.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$114.1K3,766,66660.1%
Cara Therapeutics Inc(CARAEUR)COM140755109$42.4K2,799,05822.3%
Mersana Therapeutics IncCOM59045L106$21.2K796,45811.2%
Livexlive Media IncCOM NEW53839L208$12.2K3,724,1386.4%
Senseonics Hldgs Inc(SENS1GBP)COM81727U105$139159,6010.1%